TrialEuropean journal of preventive cardiology2020

Triglyceride concentrations and non-high-density lipoprotein cholesterol goal attainment in the ODYSSEY phase 3 trials with alirocumab.

Antonio J Vallejo-Vaz et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.